Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiology
Coronary retrograde perfusion may be technique for myocardial ischemia
August 26th, 2005
A recent report describes catheter-based ventricle-coronary vein bypass. According to researchers in the United States, "The goal of [our] study was to investigate the feasibility of a catheter-based ventricle-to-coronary vein bypass (VPASS) in order to achieve retrograde myocardial perfusion by a conduit (VSTENT) from the left ventricle (LV) to the anterior interventricular vein (AIV). Percutaneous coronary venous arterialization has been proposed as a potential treatment strategy for otherwise untreatable coronary artery disease." M. Hayase and colleagues of Harvard University explained, "In an acute setting, the VSTENT implant was deployed...
Source: Drug Week (2005-08-26)
|
